A Tufts CSDD analysis values Medable's AI clinical monitoring agent at up to $21M per drug program with 82x ROI…
The oncology trial matching company joins OpenAI's Select tier to pair frontier models with cancer care workflows.
CRO giant ICON will weave Anthropic's Claude into site selection, feasibility and enrollment monitoring across its agentic Orbis platform.
Novo Nordisk partners with provider data company H1 to bring AI to trial design, enrollment and site selection.
More than 173 AI-originated drug programs are in clinical development as of early 2026, with the first potential FDA approval…
Kordata Dynamics emerges from stealth with an AI platform that processes neural data to accelerate and improve precision clinical trials…
OCTCube-M reads full volumetric OCT scans to improve retinal disease detection, cut trial sizes and open a window to systemic…